Pages that link to "Q34321215"
Jump to navigation
Jump to search
The following pages link to Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer (Q34321215):
Displaying 50 items.
- Genome-wide analysis of microRNA and mRNA expression signatures in cancer (Q26795603) (← links)
- Open tubular lab-on-column/mass spectrometry for targeted proteomics of nanogram sample amounts (Q27312175) (← links)
- Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer (Q30238915) (← links)
- Towards decision-making using individualized risk estimates for personalized medicine: A systematic review of genomic classifiers of solid tumors (Q30252422) (← links)
- Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study (Q33613616) (← links)
- Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer (Q33750119) (← links)
- Current status of gene expression profiling to assist decision making in stage II colon cancer (Q33829763) (← links)
- Risk stratification in myelodysplastic syndromes: is there a role for gene expression profiling? (Q34013786) (← links)
- Liquid biopsy: monitoring cancer-genetics in the blood (Q34356149) (← links)
- Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition (Q34522228) (← links)
- Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors (Q35057318) (← links)
- Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling (Q35792269) (← links)
- IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers (Q36289304) (← links)
- Validation of a quantitative 12-multigene expression assay (Oncotype DX(®) Colon Cancer Assay) in Korean patients with stage II colon cancer: implication of ethnic differences contributing to differences in gene expression (Q36399053) (← links)
- A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency (Q36494964) (← links)
- A new simple morphology-based risk score is prognostic in stage I/II colon cancers (Q36902960) (← links)
- Practical guidance for implementing predictive biomarkers into early phase clinical studies. (Q37286110) (← links)
- A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers (Q37413869) (← links)
- Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelled (Q37578725) (← links)
- Biomarkers in precision therapy in colorectal cancer. (Q37609130) (← links)
- Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer (Q37711623) (← links)
- Use of a computerised decision aid (DA) to inform the decision process on adjuvant chemotherapy in patients with stage II colorectal cancer: development and preliminary evaluation (Q37728416) (← links)
- Biomarkers of colorectal cancer: recent advances and future challenges (Q38259770) (← links)
- Personalized treatment for patients with colorectal cancer: role of biomarkers (Q38390834) (← links)
- The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer (Q38518401) (← links)
- Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon (Q38555225) (← links)
- Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria (Q38565991) (← links)
- Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization (Q38632574) (← links)
- Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer (Q38652227) (← links)
- Impact of MLH1 expression on tumor evolution after curative surgical tumor resection in a murine orthotopic xenograft model for human MSI colon cancer (Q38703244) (← links)
- Translating colorectal cancer genetics into clinically useful biomarkers (Q38779895) (← links)
- From tumour heterogeneity to advances in precision treatment of colorectal cancer (Q38786707) (← links)
- Molecular Diagnostic Applications in Colorectal Cancer. (Q38947671) (← links)
- Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence. (Q39180723) (← links)
- Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective (Q39381552) (← links)
- Nomogram for predicting recurrence in stage II colorectal cancer (Q39434378) (← links)
- Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm (Q41557019) (← links)
- A Novel Diagnostic Tool for Selecting Patients With Mesenchymal-Type Colon Cancer Reveals Intratumor Subtype Heterogeneity. (Q51071981) (← links)
- In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer. (Q52989643) (← links)
- Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer. (Q53028836) (← links)
- Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) colon cancer. (Q53263719) (← links)
- Biomarker for high-risk patients with stage II colon cancer. (Q54590412) (← links)
- The Application of Gene Expression Profiling in Predictions of Occult Lymph Node Metastasis in Colorectal Cancer Patients. (Q54693967) (← links)
- Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics. (Q54962725) (← links)
- Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer (Q57809354) (← links)
- Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapy (Q63883997) (← links)
- Identification of an eight-gene signature for survival prediction for patients with hepatocellular carcinoma based on integrated bioinformatics analysis (Q64072186) (← links)
- How does genome sequencing impact surgery? (Q88139964) (← links)
- Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges (Q89529095) (← links)
- Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study (Q90364776) (← links)